SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Viking Therapeutics Inc

Traders are focused on the anticipated release of VK2735 maintenance-trial data, which management has guided for Q3, with unusual intraday volume and price reversals sparking speculation that results may be leaking early. The community is divided between bulls betting the readout and potential Novo Nordisk acquisition or partnership interest will drive a rebound, and bears pointing to an extended multi-day selling streak and the CEO's cautious commentary on maintenance-dose tolerability.

Meta Platforms, Inc. engages in the development of social media applications. It builds technology that helps people connect and share, find communities, and grow businesses. It operates through the Family of Apps (FoA) and Reality Labs (RL) segments. The FoA segment consists of Facebook, Instagram, Messenger, WhatsApp, and other services. The RL segment includes augmented, mixed and virtual reality related consumer hardware, software, and content. The company was founded by Mark Elliot Zuckerberg, Dustin Moskovitz, Chris R. Hughes, Andrew McCollum, and Eduardo P. Saverin on February 4, 2004, and is headquartered in Menlo Park, CA.

Meta Platforms Inc - Ordinary Shares - Class A

Meta Platforms Inc

META is trending on a double-digit surge attributed to its Muse AI agent topping app-store download charts against rival assistants, reinforced by a Wells Fargo price-target raise ahead of the Meta Connect conference. Traders are divided between bulls citing Muse's early adoption and monetization potential and skeptics calling the move an overbought, low-volume hype pump or short squeeze, with some also flagging Amazon's decision to block Muse from its retail site.

Critical Metals Corp. engages in the mining, exploration, and development of lithium metals. It owns Wolfsberg Project and Tanbreez Project. The company was founded on October 24, 2022 and is headquartered in British Virgin Islands.

Critical Metals Corp.

Critical Metals is surging after the U.S. unveiled a security agreement with Denmark and Greenland granting Washington permanent military access, which traders see as strengthening the outlook for the company's Tanbreez rare-earth project ahead of the deal's UN signing and a Trump-Xi meeting expected to center on critical minerals. The community is split between bulls betting on a short squeeze given elevated short interest and skeptics who note the pact does not directly change mining rights, permitting, or production timelines and warn of a potential sell-the-news fade.

Advanced Micro Devices, Inc. engages in the semiconductor business. Its products include processors, accelerators, graphics, adaptive SoCs, FPGAs, and SOMs, and software, tools, and apps. The firm offers artificial intelligence, industries, workloads, and gaming solutions. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

AMD shares surged to record highs and briefly crossed the $1 trillion market-capitalization milestone amid a broad semiconductor rally. Traders are split between bulls celebrating the milestone and expecting further momentum, and skeptics flagging stretched valuation, with some locking in profits or taking short positions.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bear 3X ETF

Direxion Daily Semiconductor Bear 3X ETF

A sharp semiconductor rally is crushing the inverse chip ETF, with traders citing AI-driven momentum in SOXX/SOXL and speculating the move reflects US-China meeting optimism, liquidity flows, or market manipulation. The community is split between bears averaging down into the drop and critics warning that leveraged-ETF decay plus persistent chip strength point to further pain.

Paramount Skydance Corp. is a next-generation global media and entertainment company that engages in providing content creation and distribution services. It operates through the following business segments: Studios, Direct-to-Consumer, and TV Media. Its portfolio unites brands including Paramount Pictures, Paramount Television, CBS, CBS News, Nickelodeon, MTV, BET, Comedy Central, Showtime, Paramount Plus, Pluto TV, and Skydance’s Animation, Film, Television, Interactive/Games, and Sports divisions. The company is headquartered in New York, NY.

Paramount Skydance Corp. - Ordinary Shares - Class B

Reports that Paramount Skydance settled with California and other state attorneys general over the antitrust suits blocking its roughly $110 billion acquisition of Warner Bros. Discovery dominate the conversation, clearing a key legal hurdle with closing targeted within about two weeks. The community is split on the stock's reversal from an initial rally  some call it sell-the-news profit-taking, others allege short-selling manipulation and are buying the dip  while skeptics cite dilution, heavy merger debt, and concessions such as a 30-film annual release commitment.

AppLovin Corp. engages in the development and operation of a mobile marketing platform. It offers AppDiscovery, MAX, Adjust, and SparkLabs. Its software-based platform caters to mobile application developers to improve the marketing and monetization of applications. The company was founded by Andrew Karam, John Krystynak, and Adam Foroughi in 2011 and is headquartered in Palo Alto, CA.

Applovin Corp - Ordinary Shares - Class A

Applovin Corp

AppLovin is surging in a sharp rebound after an extended slide toward its lows, with many traders citing a Citi note flagging the company's fastest e-commerce client growth in five months as the catalyst. Bulls call the stock deeply undervalued and speculate on a short squeeze, while skeptics warn the rally could fade like earlier one-day pops amid persistent complaints about manipulation.

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark.

Novo Nordisk - ADR

Novo Nordisk A/S

Novo Nordisk is sliding sharply following its Capital Markets Day, where long-term targets  more than five blockbusters by 2030 and mid-single-digit revenue growth guided in line with industry peers  failed to ease concerns over Eli Lilly competition and the coming semaglutide patent cliff. The conversation is split between bears criticizing the cautious growth outlook and CEO Mike Doustdar's credibility, and bulls calling the selloff an overreaction and buying the dip at what they view as deeply discounted levels.

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968, and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intel is rallying sharply alongside Arm and AMD as Meta's Muse AI agent fuels expectations that agentic AI workloads will drive a surge in data-center CPU demand. Community reaction is strongly bullish, marked by heavy call buying and short-squeeze speculation, though some traders warn the move is overdone and question whether fundamentals justify the rally.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

QQQ is ripping roughly 3% in one of its largest point gains on record as it approaches all-time highs, and traders are split over the catalyst  pointing to a violent short squeeze, algorithmic and 0DTE gamma-driven buying, easing oil prices, and speculation about a USIran peace deal. Skeptics call it an unexplained, low-volume pump against elevated yields and recent rate hikes, and flag a rising VIX during the rally as a warning.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

12 Health Care Stocks Moving In Wednesday's After-Market Session

Gainers

Basel Medical Group (NASDAQ:BMGL) stock moved upwards by 14.1% to $4.68 during Wednesday's after-market session. The market value of their outstanding shares is at $8.3 million.
Alaunos Therapeuticsread more...

12 Health Care Stocks Moving In Monday's Intraday Session

Gainers

Basel Medical Group (NASDAQ:BMGL) shares moved upwards by 59.8% to $7.32 during Monday's regular session.
Scinai Immunotherapeutics (NASDAQ:SCNI) stock increased by 45.18% to $2.41. The company'sread more...

Five Stories Putting Traders on Notice: Insider Buying, FDA Catalysts, Psychedelic Breakthroughs and a U.S. Tungsten Rush

The market is once again rewarding investors willing to look beyond the headline indexes; NeOnc Technologies Holdings (NASDAQ:NTHI), Armata Pharmaceuticals (NYSEAMERICAN:ARMP), Definium Therapeutics (NASDAQ:DFTX), Basel Medical Group (NASDAQ:BMGL), Blue Moon Metals (NASDAQ:BMM) and The Elmet Group (NASDAQ:ELMT).

Why Did BMGL Stock Slump 18% Today?

Equity

Basel Medical Group’s board of directors approved a 1-for-12 reverse stock split, the first share consolidation in the company’s history.

Rosen Law Firm Encourages Basel Medical Group Ltd. Investors to Inquire About Securities Class Action Investigation BMGL

Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Basel Medical Group Ltd. (NASDAQ: BMGL) resulting from allegations that Basel Medical may have issued materially misleading business information to the...

Basel Medical Group Ltd. is an investment holding company, which engages in providing orthopedic surgeries, medical care, and diagnosis services. Its services include orthopedic surgeries, medical care, rehabilitative therapy, physiotherapy, non-surgical treatments, medical diagnosis, magnetic resonance imaging, general surgery, x-ray, lump removal, sports medicine, and total hip replacement. The company was founded by Man Hing Yip on August 10, 2023 and is headquartered in Singapore.

Basel Medical Group Ltd.

Bearish Sentiment

Rising interest rates

Surging bond yields

Oil/energy volatility

Trump/political risk

U.S. investors are navigating a stacked macro backdrop, with the Federal Reserve hiking rates for the first time since July 2023, the 10-year Treasury yield hitting 5.00% - its highest level since 2007 - and oil prices swinging between $94 and $105 a barrel amid the ongoing U.S.-Iran conflict and Saudi pipeline disruptions. What's the biggest risk to your portfolio right now? Vote and explain your reasoning in the comments.

With the Fed hiking rates for the first time since 2023, the 10-year Treasury yield near 5%, and oil prices swinging on the U.S.-Iran conflict, what&#39;s the biggest risk to your portfolio right now?

Stocktwits

With the Fed hiking rates for the first time since 2023, the 10-year Treasury yield near 5%, and oil prices swinging on the U.S.-Iran conflict, what's the biggest risk to your portfolio right now?

Feed

News

Sentiment

Fundamentals

Info

BMGL News